[HTML][HTML] Multi-night measurement for diagnosis and simplified monitoring of obstructive sleep apnoea
Substantial night-to-night variability in obstructive sleep apnoea (OSA) severity has raised
misdiagnosis and misdirected treatment concerns with the current prevailing single-night …
misdiagnosis and misdirected treatment concerns with the current prevailing single-night …
Current and novel treatment options for obstructive sleep apnoea
W Randerath, J de Lange, J Hedner… - ERJ open …, 2022 - Eur Respiratory Soc
Obstructive sleep apnoea is a challenging medical problem due to its prevalence, its impact
on quality of life and performance in school and professionally, the implications for risk of …
on quality of life and performance in school and professionally, the implications for risk of …
Treatment options in obstructive sleep apnea
F Gambino, MM Zammuto, A Virzì, G Conti… - Internal and emergency …, 2022 - Springer
Abstract Treatment of OSA with CPAP is currently the recommended treatment and has the
greatest evidence of efficacy on AHI, symptoms and comorbidities. Symptomatic patients …
greatest evidence of efficacy on AHI, symptoms and comorbidities. Symptomatic patients …
Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view
S Craig, JL Pépin, W Randerath… - European …, 2022 - Eur Respiratory Soc
Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA),
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …
One month dosing of atomoxetine plus oxybutynin in obstructive sleep apnea: a randomized, placebo-controlled trial
Rationale: The combination of noradrenergic and antimuscarinic agents has recently been
shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) severity …
shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) severity …
Respiratory effort during sleep and prevalent hypertension in obstructive sleep apnoea
JB Martinot, NN Le-Dong, A Malhotra… - European Respiratory …, 2023 - Eur Respiratory Soc
Background Mechanisms underlying blood pressure changes in obstructive sleep apnoea
(OSA) are incompletely understood. Increased respiratory effort is one of the main features …
(OSA) are incompletely understood. Increased respiratory effort is one of the main features …
Hypoglossal nerve stimulation in adolescents with down syndrome and obstructive sleep apnea: A systematic review and meta-analysis
P Liu, W Kong, C Fang, K Zhu, X Dai, X Meng - Frontiers in Neurology, 2022 - frontiersin.org
Objective To evaluate the efficacy and adverse effects of hypoglossal nerve stimulation in
adolescents with down syndrome and obstructive sleep apnea. Methods A systematic …
adolescents with down syndrome and obstructive sleep apnea. Methods A systematic …
Topical potassium channel blockage improves pharyngeal collapsibility: a translational, placebo-controlled trial
AM Osman, S Mukherjee, TJ Altree, M Delbeck… - Chest, 2023 - Elsevier
Background Potassium (K+) channel inhibition has been identified in animal models as a
potential target to increase pharyngeal dilator muscle activity and to treat OSA. However …
potential target to increase pharyngeal dilator muscle activity and to treat OSA. However …
CPAP resumption after a first termination and impact on all-cause mortality in France
JL Pépin, R Tamisier, AV Benjafield… - European …, 2024 - Eur Respiratory Soc
Background Continuation of continuous positive airway pressure (CPAP) therapy after initial
prescription has been shown to reduce all-cause mortality versus therapy termination …
prescription has been shown to reduce all-cause mortality versus therapy termination …
Pharmacological management of co-morbid obstructive sleep apnoea and insomnia
Introduction Clinical presentation of both insomnia and obstructive sleep apnea (COMISA) is
common. Approximately 30% of clinical cohorts with OSA have insomnia symptoms and vice …
common. Approximately 30% of clinical cohorts with OSA have insomnia symptoms and vice …